Mr Chandrakant I Udani, MD in Ocean City, NJ - Medicare General Practice

Mr Chandrakant I Udani, MD is a medicare enrolled "General Practice" physician in Ocean City, New Jersey. His current practice location is 5548 Asbury Ave., Ocean City, New Jersey. You can reach out to his office (for appointments etc.) via phone at (609) 399-1519.

Mr Chandrakant I Udani is licensed to practice in New Jersey (license number 25MA03731800) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1518974229.

Contact Information

	Mr Chandrakant I Udani, MD
	5548 Asbury Ave., Ocean City, NJ 08226-1236
	(609) 399-1519
	(609) 398-4712

Physician's Profile

Full Name	Mr Chandrakant I Udani
Gender	Male
Speciality	General Practice
Location	5548 Asbury Ave., Ocean City, New Jersey
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1518974229
Provider Enumeration Date: 08/02/2006
Last Update Date: 04/10/2012

Medicare PECOS Information:

PECOS PAC ID: 4789784224
Enrollment ID: I20070712000323

Medical Identifiers

Medical identifiers for Mr Chandrakant I Udani such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1518974229	NPI	-	NPPES
1490303	Medicaid	NJ

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	25MA03731800 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Chandrakant I Udani is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Chandrakant I Udani, MD 5548 Asbury Ave., Ocean City, NJ 08226 Ph: (609) 399-1519	Mr Chandrakant I Udani, MD 5548 Asbury Ave., Ocean City, NJ 08226-1236 Ph: (609) 399-1519

News Archive

Scientists develop COVID-19 test to detect neutralizing antibodies with high sensitivity, specificity

According to a study published in Nature Biotechnology, the sVNT is capable of detecting the functional neutralizing antibodies (NAbs) that can block the binding of the coronavirus spike protein to the angiotensin-converting enzyme 2 (ACE2) host receptor, which mimics the virus-host interaction.

Economic implications due to COVID-19 can have a devastating effect on children

A team of UTSA researchers has discovered that economic implications because of COVID-19 can have a devastating ripple effect on children.

Researchers study why colon cancer is more lethal in pediatric and young adult patients

Colon cancer is more likely to be lethal in children and young adults than middle-aged adults. In a single-institution study, researchers at The University of Texas MD Anderson Cancer Center, Houston, Tex., found that differences in mortality rates persist regardless of whether pediatric, adolescent, and young adult patients (aged 24 and younger) were born with a predisposition for colon abnormalities or disease and for the first time conclude that young people are more likely to have metastases outside the colon, into the abdominal cavity, when they are diagnosed.

Supernus SPN-812 Phase IIa U.S. clinical trial in ADHD meets primary endpoints

Supernus Pharmaceuticals, Inc. today announced that its Phase IIa U.S. clinical trial of SPN-812 in adults for the treatment of attention deficit hyperactivity disorder (ADHD) met the primary endpoints of safety and tolerability, and showed statistically significant median reduction versus placebo in both investigator-rated and patient-rated ADHD symptom scores.

FDA accepts Vertex's telaprevir NDA for six-month Priority Review

Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for telaprevir and granted the company's request for six-month Priority Review. Telaprevir is Vertex's lead medicine in development for people with genotype 1 chronic hepatitis C.

General Practice Doctors in Ocean City, NJ

Ms. Kathleen Patricia Denesha, RN
General Practice
Medicare: Not Enrolled in Medicare
Practice Location: 500 E 6th St, Ocean City, NJ 08226
Phone: 609-399-1862 Fax: 609-339-9157

Mr Chandrakant I Udani, MD - Medicare General Practice in Ocean City, NJ